Skip to main content

Want a detailed portfolio tracker?

Syra Health (SYRA) Income Statement (2022 - 2026)

Income Statement report data from Sep 30, 2022 to Mar 31, 2026 for Syra Health (SYRA).

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Reported currency: USD
Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Sep 30, 2022
Revenue and COGS
Total Revenue
2.27M
(+31.21%)
1.73M
(+2.37%)
1.69M
(-13.33%)
1.95M
(+4.84%)
1.86M
(-7.46%)
2.01M
(-10.67%)
2.25M
(+14.21%)
1.97M
(+12.57%)
1.75M
(-1.13%)
1.77M
(+12.03%)
1.58M
(+61.22%)
980K
(-17.65%)
1.19M
(-21.19%)
1.51M
Gross Profit
970K
(+64.41%)
590K
(+7.27%)
550K
(-26.67%)
750K
(+27.12%)
590K
(+78.79%)
330K
(-50.75%)
670K
(+91.43%)
350K
(+16.67%)
300K
(-48.28%)
580K
(+5.45%)
550K
(+323.08%)
130K
(-13.33%)
150K
(-63.41%)
410K
Operating Expenses
Research And Development
10K--30K
(-25.00%)
40K-10.00K30K
(-89.29%)
280K
(0.00%)
280K
(+16.67%)
240K----
Selling General And Administrative
210K
(-12.50%)
240K
(-4.00%)
250K
(-13.79%)
290K
(0.00%)
290K
(+61.11%)
180K
(-37.93%)
290K
(-36.96%)
460K
(-11.54%)
520K
(+10.64%)
470K
(+104.35%)
230K
(+9.52%)
210K
(-4.55%)
220K
(+46.67%)
150K
Operating Expenses
780K
(+6.85%)
730K
(-7.59%)
790K
(-3.66%)
820K
(-22.64%)
1.06M
(+26.19%)
840K
(-23.64%)
1.10M
(-36.78%)
1.74M
(0.00%)
1.74M
(+10.83%)
1.57M
(+74.44%)
900K
(-1.10%)
910K
(-1.09%)
920K
(+21.05%)
760K
Depreciation And Amortization
--10K
(0.00%)
10K
(0.00%)
10K
(0.00%)
10K
(-66.67%)
30K
(+50.00%)
20K
(+100.00%)
10K
(0.00%)
10K
(0.00%)
10K
(0.00%)
10K
(0.00%)
10K-
Operating Income
Operating Income
190K-140.00K
(-39.13%)
-230.00K
(+283.33%)
-60.00K
(-87.23%)
-470.00K
(-6.00%)
-500.00K
(+16.28%)
-430.00K
(-69.06%)
-1.39M
(-3.47%)
-1.44M
(+45.45%)
-990.00K
(+191.18%)
-340.00K
(-56.41%)
-780.00K
(+1.30%)
-770.00K
(+120.00%)
-350.00K
Ebit
190K-140.00K
(-39.13%)
-230.00K
(+283.33%)
-60.00K
(-87.23%)
-470.00K
(-6.00%)
-500.00K
(+16.28%)
-430.00K
(-69.06%)
-1.39M
(-3.47%)
-1.44M
(+45.45%)
-990.00K
(+191.18%)
-340.00K
(-56.41%)
-780.00K
(+1.30%)
-770.00K
(+120.00%)
-350.00K
EBITDA
190K-130.00K
(-43.48%)
-230.00K
(+283.33%)
-60.00K
(-87.23%)
-470.00K
(-4.08%)
-490.00K
(+22.50%)
-400.00K
(-70.80%)
-1.37M
(-4.20%)
-1.43M
(+47.42%)
-970.00K
(+193.94%)
-330.00K
(-57.14%)
-770.00K
(+1.32%)
-760.00K
(+123.53%)
-340.00K
Other Income / Expenses
Interest Income
50K
(+400.00%)
10K
(0.00%)
10K---10K-------
Interest Expense
-----10K---10K
(0.00%)
10K
(-50.00%)
20K
(+100.00%)
10K
(0.00%)
10K
Net Interest Income
50K
(+400.00%)
10K
(0.00%)
10K---10.00K10K---30.00K
(+200.00%)
-10.00K--10.00K
(0.00%)
-10.00K
Other Non Operating Income
50K
(+400.00%)
10K
(0.00%)
10K--10K
(0.00%)
10K---50.00K
(+400.00%)
-10.00K
(-50.00%)
-20.00K
(+100.00%)
-10.00K
(0.00%)
-10.00K
Net Income
Net Income From Continuing Operations
240K-130.00K
(-43.48%)
-230.00K
(+283.33%)
-60.00K
(-87.23%)
-470.00K
(-6.00%)
-500.00K
(+19.05%)
-420.00K
(-69.78%)
-1.39M
(-4.14%)
-1.45M
(+45.00%)
-1.00M
(+185.71%)
-350.00K
(-56.25%)
-800.00K
(+1.27%)
-790.00K
(+125.71%)
-350.00K
Net Income
240K-130.00K
(-43.48%)
-230.00K
(+283.33%)
-60.00K
(-87.23%)
-470.00K
(-6.00%)
-500.00K
(+19.05%)
-420.00K
(-69.78%)
-1.39M
(-4.14%)
-1.45M
(+45.00%)
-1.00M
(+185.71%)
-350.00K
(-56.25%)
-800.00K
(+1.27%)
-790.00K
(+125.71%)
-350.00K